Seth Ablordeppey, Ph.D., professor and eminent scholar chair in biomedical sciences, in the College of Pharmacy and Pharmaceutical Science, Institute of Public Health, recently received a patent for his research to identify “Alkylated tetrahydroisoquinolines for binding to central nervous system receptors.”
His work has the potential to lead to the development of novel pain medications and medications to treat drug abuse, addiction and certain sleep disorders.
Ablordeppey’s work is significant because it could spur the development of new drugs to treat pain and the symptoms of pain—specifically neuropathic and inflammatory pain, and significantly aid in discovery of new drugs to serve as alternatives to opioids as pain treatment medications.
Ablordeppey’s work is significant because it could spur the development of new drugs to treat pain and the symptoms of pain—specifically neuropathic and inflammatory pain, and significantly aid in discovery of new drugs to serve as alternatives to opioids as pain treatment medications.